SMARCA4 regulates the NK-mediated killing of senescent cells
Virinder Reen1,2, Mariantonietta D'Ambrosio1,2, Pia Pernille Søgaard1,2
1MRC Laboratory of Medical Sciences (LMS), Du Cane Road, London W12 0NN, UK.
Abstract:
Induction of senescence by chemotherapeutic agents arrests cancer cells and activates immune surveillance responses to contribute to therapy outcomes. In this investigation, we searched for ways to enhance the NK-mediated elimination of senescent cells. We used a staggered screen approach, first identifying siRNAs potentiating the secretion of immunomodulatory cytokines to later test for their ability to enhance NK-mediated killing of senescent cells. We identified that genetic or pharmacological inhibition of SMARCA4 enhanced senescent cell elimination by NK cells. SMARCA4 expression is elevated during senescence and its inhibition derepresses repetitive elements, inducing the SASP via activation of cGAS/STING and MAVS/MDA5 pathways. Moreover, a PROTAC targeting SMARCA4 synergized with cisplatin to increase the infiltration of CD8 T cells and mature, activated NK cells in an immunocompetent model of ovarian cancer. Our results indicate that SMARCA4 inhibitors enhance NK-mediated surveillance of senescent cells and may represent senotherapeutic interventions for ovarian cancer.
Insights
Targeting SMARCA4 enhances natural killer (NK) cell elimination of senescent cancer cells. This senotherapeutic approach boosts immune surveillance and may improve ovarian cancer treatment outcomes.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Chemotherapy-induced senescence can arrest cancer cells but requires immune clearance for optimal outcomes.
- Natural killer (NK) cells are crucial for eliminating senescent cells and enhancing anti-cancer immunity.
- Enhancing NK cell-mediated killing of senescent cells is a promising therapeutic strategy.
Purpose of the Study:
- To identify novel targets for enhancing NK cell-mediated elimination of senescent cancer cells.
- To investigate the role of SMARCA4 in regulating the immune response to senescent cells.
- To evaluate SMARCA4 inhibition as a senotherapeutic strategy for ovarian cancer.
Main Methods:
- Utilized a staggered siRNA screen to identify genes potentiating immunomodulatory cytokine secretion.
- Assessed the ability of identified siRNAs to enhance NK cell-mediated killing of senescent cells.
- Investigated the molecular mechanisms of SMARCA4 inhibition, including repetitive element derepression and SASP induction via cGAS/STING and MAVS/MDA5 pathways.
- Tested a PROTAC targeting SMARCA4 in combination with cisplatin in an immunocompetent ovarian cancer model.
Main Results:
- Genetic or pharmacological inhibition of SMARCA4 significantly enhanced NK cell-mediated elimination of senescent cells.
- SMARCA4 expression is upregulated during senescence; its inhibition leads to derepression of repetitive elements and induction of the senescence-associated secretory phenotype (SASP).
- SMARCA4 inhibition activates the cGAS/STING and MAVS/MDA5 pathways.
- A SMARCA4-targeting PROTAC synergized with cisplatin to increase CD8 T cell and activated NK cell infiltration in an ovarian cancer model.
Conclusions:
- SMARCA4 inhibition enhances NK cell-mediated surveillance of senescent cells.
- Targeting SMARCA4 represents a potential senotherapeutic intervention for ovarian cancer.
- This approach may improve treatment efficacy by boosting anti-tumor immune responses.
Related Concept Videos
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
The Extrinsic Apoptotic Pathway
Regulation of Hematopoietic Stem Cells
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
Replicative Cell Senescence


